Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
6 participants
INTERVENTIONAL
2024-02-19
2024-11-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using Attention Training to Reduce Adolescents' Anxious Symptoms
NCT03973580
Attention Bias Modification Training for Young People
NCT02270671
Attention Training
NCT01518738
Improving Performance of Combat Soldiers by Utilizing Attentional Training Based on Eye Tracking
NCT05306197
Cognitive Rehabilitation and Brain Activity of Attention-Control Impairment in TBI
NCT04199130
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Attention Bias Modification
Attention Bias Modification
Training attention away from threat
Attention Control Training
Attention Control Training
Training attention control
Neutral Training
Neutral training
Attention training with Neutral stimuli
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Attention Bias Modification
Training attention away from threat
Attention Control Training
Training attention control
Neutral training
Attention training with Neutral stimuli
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Palo Alto University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mikael Rubin
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Palo Alto University
Palo Alto, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-078-PAU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.